In neurodegenerative diseases, aberrant post-translational modifications of tau protein result in the loss of normal regulatory functions, which negatively impact the normal functioning of neurons and contribute to the onset and progression of neurological disorders. This evidence concerns the gene MAPT and neurodegenerative disease.